ACE2 and Respiratory tract infection: ACE2 (angiotensin-converting enzyme 2), which is expressed in the lower respiratory tract of humans, is confirmed as a cellular receptor for 2019-nCoV [5]; this receptor mediates cellular entry of the virus and causes severe and potentially fatal respiratory tract infections.